Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Guadalupe Rodriguez-Gonzalez

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Antimicrobial Chemotherapy|March 25, 2014
Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently neededMaricela Valerio, Carmen Guadalupe Rodriguez-Gonzalez, Patricia Muñoz, et al.
Journal of Evaluation in Clinical Practice|November 11, 2015
Adding value through pharmacy validation: a safety and cost perspectiveSara Ibáñez-Garcia, Carmen Guadalupe Rodriguez-Gonzalez, Maria Luisa Martin-Barbero, et al.
The Annals of Pharmacotherapy|January 9, 2020
Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected PatientsCarmen Guadalupe Rodriguez-Gonzalez, Esther Chamorro-de-Vega, Cristina Ortega-Navarro, et al.
Journal of Evaluation in Clinical Practice|August 24, 2018
Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacyCarmen Guadalupe Rodriguez-Gonzalez, Ana Herranz-Alonso, Vicente Escudero-Vilaplana, et al.
Journal of Evaluation in Clinical Practice|April 8, 2015
Use of failure mode, effect and criticality analysis to improve safety in the medication administration processCarmen Guadalupe Rodriguez-Gonzalez, Maria Luisa Martin-Barbero, Ana Herranz-Alonso, et al.
International Journal of Clinical Practice|August 25, 2017
Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC projectEsther Chamorro-de-Vega, Carmen Guadalupe Rodriguez-Gonzalez, Alvaro Gimenez-Manzorro, et al.
Journal of the American Medical Informatics Association : JAMIA|September 6, 2011
Prevalence of medication administration errors in two medical units with automated prescription and dispensingCarmen Guadalupe Rodriguez-Gonzalez, Ana Herranz-Alonso, Maria Luisa Martin-Barbero, et al.
Expert Opinion on Drug Safety|January 13, 2018
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort studyEsther Chamorro-de-Vega, Alvaro Gimenez-Manzorro, Carmen-Guadalupe Rodriguez-Gonzalez, et al.
Health Informatics Journal|January 9, 2020
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safetyMBelén Marzal-Alfaro, Carmen Guadalupe Rodriguez-Gonzalez, Vicente Escudero-Vilaplana, et al.
The Annals of Pharmacotherapy|July 17, 2016
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical PracticeEsther Chamorro-de-Vega, Alvaro Gimenez-Manzorro, Carmen Guadalupe Rodriguez-Gonzalez, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|March 25, 2014
Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently neededMaricela Valerio, Carmen Guadalupe Rodriguez-Gonzalez, Patricia Muñoz, et al.
Journal of Evaluation in Clinical Practice|November 11, 2015
Adding value through pharmacy validation: a safety and cost perspectiveSara Ibáñez-Garcia, Carmen Guadalupe Rodriguez-Gonzalez, Maria Luisa Martin-Barbero, et al.
The Annals of Pharmacotherapy|January 9, 2020
Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected PatientsCarmen Guadalupe Rodriguez-Gonzalez, Esther Chamorro-de-Vega, Cristina Ortega-Navarro, et al.
Journal of Evaluation in Clinical Practice|August 24, 2018
Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacyCarmen Guadalupe Rodriguez-Gonzalez, Ana Herranz-Alonso, Vicente Escudero-Vilaplana, et al.
Journal of Evaluation in Clinical Practice|April 8, 2015
Use of failure mode, effect and criticality analysis to improve safety in the medication administration processCarmen Guadalupe Rodriguez-Gonzalez, Maria Luisa Martin-Barbero, Ana Herranz-Alonso, et al.
International Journal of Clinical Practice|August 25, 2017
Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC projectEsther Chamorro-de-Vega, Carmen Guadalupe Rodriguez-Gonzalez, Alvaro Gimenez-Manzorro, et al.
Journal of the American Medical Informatics Association : JAMIA|September 6, 2011
Prevalence of medication administration errors in two medical units with automated prescription and dispensingCarmen Guadalupe Rodriguez-Gonzalez, Ana Herranz-Alonso, Maria Luisa Martin-Barbero, et al.
Expert Opinion on Drug Safety|January 13, 2018
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort studyEsther Chamorro-de-Vega, Alvaro Gimenez-Manzorro, Carmen-Guadalupe Rodriguez-Gonzalez, et al.
Health Informatics Journal|January 9, 2020
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safetyMBelén Marzal-Alfaro, Carmen Guadalupe Rodriguez-Gonzalez, Vicente Escudero-Vilaplana, et al.
The Annals of Pharmacotherapy|July 17, 2016
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical PracticeEsther Chamorro-de-Vega, Alvaro Gimenez-Manzorro, Carmen Guadalupe Rodriguez-Gonzalez, et al.
Pageof 2